• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ADMA Biologics Inc - Common Stock (NQ:ADMA)

    17.79 -0.45 (-2.47%)
    Streaming Delayed Price Updated: 11:58 AM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 638,586
    Open 18.37
    Bid (Size) 17.78 (100)
    Ask (Size) 17.80 (200)
    Prev. Close 18.24
    Today's Range 17.78 - 18.75
    52wk Range 13.50 - 25.67
    Shares Outstanding 196,357,149
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗
    When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗
    ANI is firing on all cylinders operationally, which makes this exit less about fundamentals and more about portfolio discipline at a moment when expectations might be sky-high. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    N/A
    N/A
    1 Month
    -7.6%
    -7.6%
    3 Month
    +22.4%
    +22.4%
    6 Month
    -2.7%
    -2.7%
    1 Year
    -1.0%
    -1.0%

    More News

    Read More
    News headline image
    ADMA Biologics Inc (NASDAQ:ADMA) Emerges as a Top GARP Investment Candidate ↗
    Via Chartmill
    News headline image
    ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 5, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 6, 2025 ↗
    Via Benzinga
    News headline image
    Is ADMA Biologics Gaining or Losing Market Support? ↗
    Via Benzinga
    News headline image
    This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why ↗
    Via The Motley Fool
    News headline image
    ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    News headline image
    Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Is ADMA Biologics Gaining or Losing Market Support? ↗
    Via Benzinga
    News headline image
    How Is The Market Feeling About ADMA Biologics? ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Adma Biologics (ADMA) Q2 Revenue Up 14% ↗
    Via The Motley Fool
    Topics Economy
    News headline image
    ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    News headline image
    ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    News headline image
    ADMA BIOLOGICS INC (NASDAQ:ADMA) - A Strong Growth Candidate Meeting Minervini's Criteria ↗
    Via Chartmill
    News headline image
    ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Strong Growth Stock with Technical Breakout Potential ↗
    Via Chartmill
    News headline image
    ADMA BIOLOGICS INC (NASDAQ:ADMA) – A High Growth Momentum Stock with Strong Technical Setup ↗
    Via Chartmill
    News headline image
    ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Promising Affordable Growth Stock ↗
    Via Chartmill
    News headline image
    ADMA BIOLOGICS INC (NASDAQ:ADMA) is not too expensive for the growth it is showing. ↗
    Via Chartmill
    News headline image
    Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings ↗
    Via Benzinga
    News headline image
    Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits ↗
    Via Investor's Business Daily
    Topics Earnings
    News headline image
    ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
    From ADMA Biologics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is ADMA Biologics Inc - Common Stock publicly traded?
    Yes, ADMA Biologics Inc - Common Stock is publicly traded.
    What exchange does ADMA Biologics Inc - Common Stock trade on?
    ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for ADMA Biologics Inc - Common Stock?
    The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market
    What is the current price of ADMA Biologics Inc - Common Stock?
    The current price of ADMA Biologics Inc - Common Stock is 17.79
    When was ADMA Biologics Inc - Common Stock last traded?
    The last trade of ADMA Biologics Inc - Common Stock was at 01/02/26 11:58 AM ET
    What is the market capitalization of ADMA Biologics Inc - Common Stock?
    The market capitalization of ADMA Biologics Inc - Common Stock is 3.49B
    How many shares of ADMA Biologics Inc - Common Stock are outstanding?
    ADMA Biologics Inc - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.